In cohort studies, what differentiates the induction period from the latency period, and why does it matter?

• A. Induction period is the time from exposure to disease onset; latency period is the time from disease onset to diagnosis; Both affect timing of exposure classification and risk estimation.
• B. Induction period is from diagnosis to treatment; latency is death; They don't affect exposure classification.
• C. Induction period is from exposure to treatment; latency is from exposure to disease onset; Latency affects sample size.
• D. Induction period is from birth to exposure; latency is from exposure to death; Both affect follow-up duration.

Answer: (A)

In cohort studies the key is the timeline linking exposure, disease development, and diagnosis. The induction period is the biologic window from when exposure occurs to when the disease process actually begins. The latency period is the later window from that disease onset to when it is clinically diagnosed. This matters because exposure classification and the estimation of risk depend on when the exposure could plausibly cause disease and when cases are actually captured in the data. If you don’t account for the induction period, you may misclassify person-time or misalign the exposure window with the disease process, biasing the effect estimate. Similarly, the latency period affects when cases are detected and counted, which can influence observed associations and lead to timing-related biases if not properly handled. By recognizing both periods, you can better time exposure assessment (sometimes using lag times) and interpret risk estimates accurately.